Tag: Allergy and Critical Care Advisory Committee

neffy®

FDA Schedules Review of neffy®, an Intranasal Alternative to Epinephrine Auto-Injectors

Meeting signals the FDA believes neffy has potential for approval given data gleaned from clinical trials.